Publication A comprehensive research agenda for zero leprosy Steinmann P, Dusenbury C, Addiss D, et al. Springer Science and Business Media LLC. Infectious Diseases of Poverty. 2020; Download PDF
Publication The State of Affairs in Post-Exposure Leprosy Prevention: A Descriptive Meta-Analysis on Immuno- and Chemo-Prophylaxis Schoenmakers A, Mieras L, Budiawan T, et al. Informa UK Limited. Research and Reports in Tropical Medicine. 2020; Download PDF
Publication Post-exposure prophylaxis (PEP) efficacy of rifampin, rifapentine, moxifloxacin, minocycline, and clarithromycin in a susceptible-subclinical model of leprosy. Lenz SM, Collins J, Ray N, et al. PLoS neglected tropical diseases. 2020; 14 (9) : e0008583. Download PDF
Publication Jopling's Handbook of Leprosy, 6/E Sardana K, Khurana A. CBS Publishers & Distributors. 2020; Download PDF
Publication CHEMOPROPHYLAXIS VERSUS IMMUNOPROPHYLAXIS IN TUBERCULOSIS AND LEPROSY INFECTION Novita BD. Jurnal Widya Medika. 2020; 6 (1) : 65-71.
Publication Report of the first meeting of the WHO Diagnostic Technical Advisory Group for Neglected Tropical Diseases World Health Organization (WHO) . World Health Organization. 2020; Download PDF
Publication Potential Public Health Measures to Tackle Skin Diseases Mphande FA. Springer Singapore. Skin Disorders in Vulnerable Populations. 2020;
Publication [Acceptability of chemoprophylaxis in an endemic area for leprosy: the PEP-Hans Brazil Project]. Cortela D, Ferreira SM B, Virmond M, et al. Cadernos de saude publica. 2020; 36 (3) : e00068719. Download PDF
Publication Leprosy: Treatment and Management of Complications. Maymone M, Venkatesh S, Laughter M, et al. Journal of the American Academy of Dermatology. 2020;
Publication Preventing Leprosy: Epidemiological and immunological aspects of chemo- and immunoprophylaxis in leprosy patients’ contacts Richardus R. Leiden University. Leiden University of Medical Center. 2020; Download PDF
